These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 23897970

  • 1. Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer.
    Yennurajalingam S, Frisbee-Hume S, Palmer JL, Delgado-Guay MO, Bull J, Phan AT, Tannir NM, Litton JK, Reddy A, Hui D, Dalal S, Massie L, Reddy SK, Bruera E.
    J Clin Oncol; 2013 Sep 01; 31(25):3076-82. PubMed ID: 23897970
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Combination Therapy of Physical Activity and Dexamethasone for Cancer-Related Fatigue: A Phase II Randomized Double-Blind Controlled Trial.
    Yennurajalingam S, Valero V, Lu Z, Liu DD, Busaidy NL, Reuben JM, Diaz Fleming C, Williams JL, Hess KR, Basen-Engquist K, Bruera E.
    J Natl Compr Canc Netw; 2021 Dec 29; 20(3):235-243. PubMed ID: 34965510
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Donepezil for cancer fatigue: a double-blind, randomized, placebo-controlled trial.
    Bruera E, El Osta B, Valero V, Driver LC, Pei BL, Shen L, Poulter VA, Palmer JL.
    J Clin Oncol; 2007 Aug 10; 25(23):3475-81. PubMed ID: 17687152
    [Abstract] [Full Text] [Related]

  • 7. Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial.
    Bruera E, Valero V, Driver L, Shen L, Willey J, Zhang T, Palmer JL.
    J Clin Oncol; 2006 May 01; 24(13):2073-8. PubMed ID: 16648508
    [Abstract] [Full Text] [Related]

  • 8. Melatonin Supplementation for Cancer-Related Fatigue in Patients With Early Stage Breast Cancer Receiving Radiotherapy: A Double-Blind Placebo-Controlled Trial.
    Mukhopadhyay ND, Khorasanchi A, Pandey S, Nemani S, Parker G, Deng X, Arthur DW, Urdaneta A, Del Fabbro E.
    Oncologist; 2024 Feb 02; 29(2):e206-e212. PubMed ID: 37699115
    [Abstract] [Full Text] [Related]

  • 9. Methylphenidate Versus Placebo for Treating Fatigue in Patients With Advanced Cancer: Randomized, Double-Blind, Multicenter, Placebo-Controlled Trial.
    Stone PC, Minton O, Richardson A, Buckle P, Enayat ZE, Marston L, Freemantle N.
    J Clin Oncol; 2024 Jul 10; 42(20):2382-2392. PubMed ID: 38757263
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Potential Role of Bupropion Sustained Release for Cancer-Related Fatigue: a Double-Blind, Placebo-Controlled Study.
    Ashrafi F, Mousavi S, Karimi M.
    Asian Pac J Cancer Prev; 2018 Jun 25; 19(6):1547-1551. PubMed ID: 29936730
    [Abstract] [Full Text] [Related]

  • 12. Effects of methylphenidate on fatigue and depression: a randomized, double-blind, placebo-controlled trial.
    Kerr CW, Drake J, Milch RA, Brazeau DA, Skretny JA, Brazeau GA, Donnelly JP.
    J Pain Symptom Manage; 2012 Jan 25; 43(1):68-77. PubMed ID: 22208450
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of methylprednisolone on pain, fatigue, and appetite loss in patients with advanced cancer using opioids: a randomized, placebo-controlled, double-blind trial.
    Paulsen O, Klepstad P, Rosland JH, Aass N, Albert E, Fayers P, Kaasa S.
    J Clin Oncol; 2014 Oct 10; 32(29):3221-8. PubMed ID: 25002731
    [Abstract] [Full Text] [Related]

  • 14. Clinically important improvement in the intensity of fatigue in patients with advanced cancer.
    Reddy S, Bruera E, Pace E, Zhang K, Reyes-Gibby CC.
    J Palliat Med; 2007 Oct 10; 10(5):1068-75. PubMed ID: 17985963
    [Abstract] [Full Text] [Related]

  • 15. Parenteral hydration in patients with advanced cancer: a multicenter, double-blind, placebo-controlled randomized trial.
    Bruera E, Hui D, Dalal S, Torres-Vigil I, Trumble J, Roosth J, Krauter S, Strickland C, Unger K, Palmer JL, Allo J, Frisbee-Hume S, Tarleton K.
    J Clin Oncol; 2013 Jan 01; 31(1):111-8. PubMed ID: 23169523
    [Abstract] [Full Text] [Related]

  • 16. Cancer-related fatigue among patients with advanced cancer receiving immune-checkpoint inhibitors: a prospective study.
    Yennurajalingam S, Thomas L, Stanton PA, Lu Z, de Moraes AR, Bruera E.
    Support Care Cancer; 2024 Jun 25; 32(7):459. PubMed ID: 38918253
    [Abstract] [Full Text] [Related]

  • 17. Open-Label Placebo for the Treatment of Cancer-Related Fatigue in Patients with Advanced Cancer: A Randomized Controlled Trial.
    Yennurajalingam S, Azhar A, Lu Z, Rodriguez AJ, Arechiga AB, Guerra-Sanchez M, Stanton P, Andersen CR, Urbauer DL, Bruera E.
    Oncologist; 2022 Dec 09; 27(12):1081-1089. PubMed ID: 36106759
    [Abstract] [Full Text] [Related]

  • 18. Factors associated with response to methylphenidate in advanced cancer patients.
    Yennurajalingam S, Palmer JL, Chacko R, Bruera E.
    Oncologist; 2011 Dec 09; 16(2):246-53. PubMed ID: 21282671
    [Abstract] [Full Text] [Related]

  • 19. Testosterone replacement for fatigue in hypogonadal ambulatory males with advanced cancer: a preliminary double-blind placebo-controlled trial.
    Del Fabbro E, Garcia JM, Dev R, Hui D, Williams J, Engineer D, Palmer JL, Schover L, Bruera E.
    Support Care Cancer; 2013 Sep 09; 21(9):2599-607. PubMed ID: 23653013
    [Abstract] [Full Text] [Related]

  • 20. Effects of Dexamethasone and Placebo on Symptom Clusters in Advanced Cancer Patients: A Preliminary Report.
    Yennurajalingam S, Williams JL, Chisholm G, Bruera E.
    Oncologist; 2016 Mar 09; 21(3):384-90. PubMed ID: 26888692
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.